Identification Generic Name (1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone DrugBank Accession Number DB03062 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone (DB03062) ×  Close Weight Average: 404.4617  Monoisotopic: 404.184840654  Chemical Formula C 23 H 24 N 4 O 3 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Glycylpeptide N-tetradecanoyltransferase 1 Not Available Humans U Glycylpeptide N-tetradecanoyltransferase Not Available Yeast Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Dietary Supplements 
 Supplements Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as benzofurans. These are organic compounds containing a benzene ring fused to a furan. Furan is a five-membered aromatic ring with four carbon atoms and one oxygen atom. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Benzofurans Sub Class Not Available Direct Parent Benzofurans Alternative Parents Aryl ketones  /  Aralkylamines  /  Alkyl aryl ethers  /  Pyridines and derivatives  /  N-substituted imidazoles  /  Benzenoids  /  Heteroaromatic compounds  /  Furans  /  Oxacyclic compounds  /  Dialkylamines  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organic oxides  /  Hydrocarbon derivatives 
 
 
  show 4 more Substituents Alkyl aryl ether  /  Amine  /  Aralkylamine  /  Aromatic heteropolycyclic compound  /  Aryl ketone  /  Azacycle  /  Azole  /  Benzenoid  /  Benzofuran  /  Ether  /  Furan  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Imidazole  /  Ketone  /  N-substituted imidazole  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Oxacycle  /  Pyridine  /  Secondary aliphatic amine  /  Secondary amine 
 
 
  show 16 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key VZBQJKIOAOUYJL-UHFFFAOYSA-N InChI InChI=1S/C23H24N4O3/c1-16-20-18(29-13-5-10-25-15-17-6-4-9-24-14-17)7-3-8-19(20)30-22(16)21(28)23-26-11-12-27(23)2/h3-4,6-9,11-12,14,25H,5,10,13,15H2,1-2H3 IUPAC Name (3-{[3-methyl-2-(1-methyl-1H-imidazole-2-carbonyl)-1-benzofuran-4-yl]oxy}propyl)[(pyridin-3-yl)methyl]amine SMILES CN1C=CN=C1C(=O)C1=C(C)C2=C(O1)C=CC=C2OCCCNCC1=CN=CC=C1 References General References Not Available External Links PubChem Compound 446386 PubChem Substance 46505140 ChemSpider 393760 BindingDB 50121720 ChEMBL CHEMBL355497 ZINC ZINC000003581083 PDBe Ligand R64 PDB Entries 1iyl Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0425 mg/mL ALOGPS logP 2.83 ALOGPS logP 2.55 Chemaxon logS -4 ALOGPS pKa (Strongest Basic) 8.79 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 82.18 Å 2 Chemaxon Rotatable Bond Count 9 Chemaxon Refractivity 114.23 m 3 ·mol -1 Chemaxon Polarizability 44.88 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.9235 Caco-2 permeable + 0.6351 P-glycoprotein substrate Substrate 0.8147 P-glycoprotein inhibitor I Inhibitor 0.5912 P-glycoprotein inhibitor II Inhibitor 0.5211 Renal organic cation transporter Inhibitor 0.5258 CYP450 2C9 substrate Non-substrate 0.8486 CYP450 2D6 substrate Non-substrate 0.5766 CYP450 3A4 substrate Substrate 0.5884 CYP450 1A2 substrate Inhibitor 0.7656 CYP450 2C9 inhibitor Non-inhibitor 0.8695 CYP450 2D6 inhibitor Non-inhibitor 0.6895 CYP450 2C19 inhibitor Non-inhibitor 0.9189 CYP450 3A4 inhibitor Inhibitor 0.5 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.5517 Ames test Non AMES toxic 0.6532 Carcinogenicity Non-carcinogens 0.9137 Biodegradation Not ready biodegradable 0.9811 Rat acute toxicity 2.4392 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.5342 hERG inhibition (predictor II) Inhibitor 0.5371    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 69 N/A N/A A30097 
 
 
  Details 
 
 
   Binding Properties 1.  Glycylpeptide N-tetradecanoyltransferase 1 Kind Protein Organism Humans Pharmacological action Unknown General Function Glycylpeptide n-tetradecanoyltransferase activity Specific Function Adds a myristoyl group to the N-terminal glycine residue of certain cellular and viral proteins. Gene Name NMT1 Uniprot ID P30419 Uniprot Name Glycylpeptide N-tetradecanoyltransferase 1 Molecular Weight 56805.865 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  
 
 
  Details 2.  Glycylpeptide N-tetradecanoyltransferase Kind Protein Organism Yeast Pharmacological action Unknown General Function Glycylpeptide n-tetradecanoyltransferase activity Specific Function Adds a myristoyl group to the N-terminal glycine residue of certain cellular proteins. Substrate specificity requires an N-terminal glycine in the nascent polypeptide substrates. Ser is present at ... Gene Name NMT1 Uniprot ID P30418 Uniprot Name Glycylpeptide N-tetradecanoyltransferase Molecular Weight 51876.7 Da References Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [ Article ]  Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 